Amarin Pharma, Inc. et al v. Roxane Laboratories, Inc. et.al,
Filing 142
ORDER that due to conflicting duties of the Court, the settlement conference set in this case is hereby ADVANCED to 9:30 a.m. on October 9, 2018. Settlement statements shall be submitted by 3:00 p.m. on October 2, 2018. All other requirements in the order at Docket No. 136 continue to govern. Signed by Magistrate Judge Nancy J. Koppe on 8/30/2018. (Copies have been distributed pursuant to the NEF - LH)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
